Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Purpose

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Conditions

  • Cancer Screening
  • Transgender
  • Gender Diverse Populations

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years and older - Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent - Able to understand, speak, read, and write in English - Patients who have undergone hysterectomy, or plan to have a hysterectomy - Patients who are transgender and gender diverse"

Exclusion Criteria

  • Opted out of research - <18 years old - Lacks capacity to consent/has diminished capacity to consent - Cannot provide informed consent - Those on the study's community advisory board

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Standard of Care Cancer Screening
  • Other: No intervention
    Observational study
FDA approved self swab
  • Other: No intervention
    Observational study
Mock self swab
  • Other: No intervention
    Observational study

Recruiting Locations

University of Minnesota
Minneota, Minnesota 55455
Contact:
Samantha Hoffman, MD
612-273-7117
kehoe018@umn.edu

More Details

Status
Recruiting
Sponsor
University of Minnesota

Study Contact

Samantha Hoffman, MD
(612)273-7117
kehoe018@umn.edu